Professor Brandon Wainwright, Director of the Institute for Molecular Bioscience

Professor Brandon Wainwright

BSc (Hons) Adelaide, PhD Adelaide

Phone: +61 (7) 3346 2110
Fax: +61 (7) 3346 2111
Email: director@imb.uq.edu.au
Website: www.imb.uq.edu.au
Office: Level 4 West, Queensland Bioscience Precinct (Building 80 [See map])
Post:    Institute for Molecular Bioscience 
           The University of Queensland 
           St Lucia QLD 4072

Executive Administrative Officer
Jenny Greder
Phone: +61 (7) 3346 2110
Email: j.greder@imb.uq.edu.au

Areas of responsibility
Professor Wainwright is Director of the Institute for Molecular Bioscience (IMB), and is responsible for its strategic directions, scientific appointments, budgets, performance, representation and reporting to stakeholders.

Biography
Professor Wainwright was appointed Director of the Institute for Molecular Bioscience in December 2006. Previously, he was Deputy Director (Research) of the IMB. Professor Wainwright joined UQ in 1990 as a Senior Lecturer in the Centre for Molecular and Cellular Biology and the Department of Biochemistry.

Professor Wainwright was born in Melbourne and was educated at the University of Adelaide. Before coming to UQ, he worked at the University of London. He has won several awards, including the Boehringer Mannheim Medal of the Australian Society for Biochemistry and Molecular Biology (1991), the Gottschalk Medal of the Australian Academy of Science (1998). He serves on several boards and on the Health and Medical Research Council of Queensland.

The major focus of his laboratory is the use of genomic approaches to dissect the basis of common genetic disease. In particular, his team has focused on two heritable conditions, cystic fibrosis and basal cell carcinoma of the skin. Through the mapping and isolation of the genes that are responsible for these diseases they have continued to follow through on each in order to understand how the genetic defects lead to the disease. Ultimately this will provide them with validated targets against which they can develop potential therapeutics.

On this site